Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Sende Biological Technology is a specialized manufacturer of animal-derived active pharmaceutical ingredients (APIs) and biochemical products based in Heze, China. The company focuses on the extraction, isolation, and purification of high-value substances including Heparin Sodium, Pancreatin, and Chondroitin Sulfate from porcine sources. Their facilities are designed to meet international GMP standards, supplying raw materials to pharmaceutical, nutraceutical, and cosmetic companies globally. In addition to its core products, Shandong Sende produces various enzymes and bile derivatives such as Pepsin, Bilirubin, and Cholic Acid. The company is a significant contributor to the global supply of heparin-related products and maintains a strong focus on quality control and large-scale production efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Sende.